Bain Capital nears acquisition of Apleona Group for $4.2 bln, Bloomberg reports
Bain Capital, the Boston-based private equity firm, is reportedly nearing the acquisition of Apleona Group GmbH, a German ...
Bain buys 340-year-old pharma company to fast-track Japan’s drug development
Private equity firm expects $3.3bn acquisition of Tanabe will get boost from eased approval process for new medicine ...
Bain Capital buys Japanese pharma for $3.3B
Bain Capital said the deal came about following several recent initiatives by the Japanese government and regulators to ...